NPI: 1407161920 · HAYWARD, CA 94544 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 08/09/2010
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 08/09/2010 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 19,001 | $957K |
| 2019 | 18,503 | $970K |
| 2020 | 18,454 | $1.07M |
| 2021 | 14,311 | $1.15M |
| 2022 | 16,929 | $1.05M |
| 2023 | 15,946 | $1.41M |
| 2024 | 13,144 | $1.62M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 44,093 | 3,594 | $8.11M |
| A4657 | Syringe, with or without needle, each | 12,562 | 2,710 | $60K |
| J1270 | Injection, doxercalciferol, 1 mcg | 15,802 | 1,363 | $21K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,090 | 1,586 | $15K |
| J1756 | Injection, iron sucrose, 1 mg | 8,898 | 2,227 | $8K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,241 | 791 | $3K |
| 90674 | 67 | 66 | $964.53 | |
| 83970 | 891 | 883 | $375.32 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 402 | 319 | $369.25 |
| 90662 | 26 | 26 | $297.60 | |
| 82728 | 570 | 557 | $105.88 | |
| 85041 | 1,386 | 1,312 | $79.60 | |
| 83550 | 420 | 405 | $67.95 | |
| 85048 | 1,367 | 1,294 | $67.29 | |
| 83540 | 587 | 565 | $50.36 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 137 | 136 | $28.08 |
| 82108 | 45 | 45 | $24.17 | |
| 0250 | 3,704 | 218 | $0.00 |